FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306832729> ?p ?o ?g. }

• W4306832729 endingPage "1778" @default.
• W4306832729 startingPage "1758" @default.
• W4306832729 abstract "Phosphodiesterase 3A (PDE3A) gain-of-function mutations cause hypertension with brachydactyly (HTNB) and lead to stroke. Increased peripheral vascular resistance, rather than salt retention, is responsible. It is surprising that the few patients with HTNB examined so far did not develop cardiac hypertrophy or heart failure. We hypothesized that, in the heart, PDE3A mutations could be protective.We studied new patients. CRISPR-Cas9-engineered rat HTNB models were phenotyped by telemetric blood pressure measurements, echocardiography, microcomputed tomography, RNA-sequencing, and single nuclei RNA-sequencing. Human induced pluripotent stem cells carrying PDE3A mutations were established, differentiated to cardiomyocytes, and analyzed by Ca2+ imaging. We used Förster resonance energy transfer and biochemical assays.We identified a new PDE3A mutation in a family with HTNB. It maps to exon 13 encoding the enzyme's catalytic domain. All hitherto identified HTNB PDE3A mutations cluster in exon 4 encoding a region N-terminally from the catalytic domain of the enzyme. The mutations were recapitulated in rat models. Both exon 4 and 13 mutations led to aberrant phosphorylation, hyperactivity, and increased PDE3A enzyme self-assembly. The left ventricles of our patients with HTNB and the rat models were normal despite preexisting hypertension. A catecholamine challenge elicited cardiac hypertrophy in HTNB rats only to the level of wild-type rats and improved the contractility of the mutant hearts, compared with wild-type rats. The β-adrenergic system, phosphodiesterase activity, and cAMP levels in the mutant hearts resembled wild-type hearts, whereas phospholamban phosphorylation was decreased in the mutants. In our induced pluripotent stem cell cardiomyocyte models, the PDE3A mutations caused adaptive changes of Ca2+ cycling. RNA-sequencing and single nuclei RNA-sequencing identified differences in mRNA expression between wild-type and mutants, affecting, among others, metabolism and protein folding.Although in vascular smooth muscle, PDE3A mutations cause hypertension, they confer protection against hypertension-induced cardiac damage in hearts. Nonselective PDE3A inhibition is a final, short-term option in heart failure treatment to increase cardiac cAMP and improve contractility. Our data argue that mimicking the effect of PDE3A mutations in the heart rather than nonselective PDE3 inhibition is cardioprotective in the long term. Our findings could facilitate the search for new treatments to prevent hypertension-induced cardiac damage." @default.
• W4306832729 created "2022-10-20" @default.
• W4306832729 creator A5004028270 @default.
• W4306832729 creator A5005353152 @default.
• W4306832729 creator A5005946355 @default.
• W4306832729 creator A5006568947 @default.
• W4306832729 creator A5011271772 @default.
• W4306832729 creator A5015084601 @default.
• W4306832729 creator A5016421296 @default.
• W4306832729 creator A5023445706 @default.
• W4306832729 creator A5024026040 @default.
• W4306832729 creator A5025326731 @default.
• W4306832729 creator A5028239876 @default.
• W4306832729 creator A5035944523 @default.
• W4306832729 creator A5039371456 @default.
• W4306832729 creator A5040102033 @default.
• W4306832729 creator A5042397877 @default.
• W4306832729 creator A5045412621 @default.
• W4306832729 creator A5048185763 @default.
• W4306832729 creator A5048994608 @default.
• W4306832729 creator A5050660530 @default.
• W4306832729 creator A5051457908 @default.
• W4306832729 creator A5056429688 @default.
• W4306832729 creator A5057407039 @default.
• W4306832729 creator A5058205173 @default.
• W4306832729 creator A5058632283 @default.
• W4306832729 creator A5059387861 @default.
• W4306832729 creator A5061208512 @default.
• W4306832729 creator A5062027051 @default.
• W4306832729 creator A5064157132 @default.
• W4306832729 creator A5064896089 @default.
• W4306832729 creator A5068664764 @default.
• W4306832729 creator A5070514637 @default.
• W4306832729 creator A5073174320 @default.
• W4306832729 creator A5073638937 @default.
• W4306832729 creator A5075484221 @default.
• W4306832729 creator A5076055792 @default.
• W4306832729 creator A5080259827 @default.
• W4306832729 creator A5081811761 @default.
• W4306832729 creator A5083247500 @default.
• W4306832729 creator A5085075847 @default.
• W4306832729 creator A5090518995 @default.
• W4306832729 creator A5090886217 @default.
• W4306832729 creator A5090999309 @default.
• W4306832729 creator A5007416768 @default.
• W4306832729 date "2022-12-06" @default.
• W4306832729 modified "2023-10-02" @default.
• W4306832729 title "Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage" @default.
• W4306832729 cites W1537435549 @default.
• W4306832729 cites W1863660946 @default.
• W4306832729 cites W1963751073 @default.
• W4306832729 cites W1965475055 @default.
• W4306832729 cites W1967213131 @default.
• W4306832729 cites W1973567860 @default.
• W4306832729 cites W2002117545 @default.
• W4306832729 cites W2015183535 @default.
• W4306832729 cites W2018961120 @default.
• W4306832729 cites W2036028667 @default.
• W4306832729 cites W2050672068 @default.
• W4306832729 cites W2065609360 @default.
• W4306832729 cites W2075281403 @default.
• W4306832729 cites W2081970575 @default.
• W4306832729 cites W2091196412 @default.
• W4306832729 cites W2095309637 @default.
• W4306832729 cites W2108714987 @default.
• W4306832729 cites W2131642914 @default.
• W4306832729 cites W2138207763 @default.
• W4306832729 cites W2154308897 @default.
• W4306832729 cites W2160443244 @default.
• W4306832729 cites W2169456326 @default.
• W4306832729 cites W2179438025 @default.
• W4306832729 cites W2260480416 @default.
• W4306832729 cites W2334214664 @default.
• W4306832729 cites W2345356016 @default.
• W4306832729 cites W2518899468 @default.
• W4306832729 cites W2521064640 @default.
• W4306832729 cites W2542792657 @default.
• W4306832729 cites W2788195108 @default.
• W4306832729 cites W2789384773 @default.
• W4306832729 cites W2794118674 @default.
• W4306832729 cites W2800392236 @default.
• W4306832729 cites W2891388677 @default.
• W4306832729 cites W2928665623 @default.
• W4306832729 cites W2937552342 @default.
• W4306832729 cites W2951581523 @default.
• W4306832729 cites W3015160048 @default.
• W4306832729 cites W3034015560 @default.
• W4306832729 cites W3087268650 @default.
• W4306832729 cites W3088401235 @default.
• W4306832729 cites W3106188259 @default.
• W4306832729 cites W3109717749 @default.
• W4306832729 cites W3163682241 @default.
• W4306832729 cites W3179040460 @default.
• W4306832729 cites W3181471647 @default.
• W4306832729 cites W3214426622 @default.
• W4306832729 cites W3216867216 @default.
• W4306832729 cites W4225988882 @default.
• W4306832729 cites W4294216483 @default.

• next